Rakuten Medical, a developer of cancer treatments partly owned by Japan’s Rakuten Group, completed a fundraising round as it ...

Aligned with U.S. Food and Drug Administration (FDA) on Registrational Path for RE104 in Postpartum Depression (PPD); On Track to Initiate ...

The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...

EMA approval decision for obicetrapib and obicetrapib/ezetimibe fixed dose combo expected in 2H26 ---- Phase 3 PREVAIL CVOT overall event rate ...

Arrowhead heralded the results as proof of concept that inhibiting the Activin E pathway can improve body composition and ...

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...

On January 9, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with US based biotech AirNexis. Under the agreement, ...

A clinical-stage biotechnology company headquartered in Palo Alto, California. The company is focused on respiratory medicine ...

In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.

Researchers at King's have been awarded £2.1m in funding to take a new regenerative, cell-based therapy for leg pain caused by reduced blood flow to ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

Your Year of Miracles opens 2026 enrollment for a year-long online mentoring program, plus a new free ebook and ...